ℹ️ Observational Association Only Evidence
This cross-sectional study compared 261 posthospitalization and 2,068 nonhospitalized Neuro-PASC patients evaluated at one Neuro-COVID clinic from 2020 through 2025. Females in both cohorts reported a higher median neurologic symptom count and more frequently had at least four symptoms. The findings identify clinically relevant sex-associated patterns but do not establish causality, biological mechanisms, or population prevalence.
Clinical Considerations
- At least four neurologic symptoms affected 79.6% of posthospitalization females versus 64.9% of males.
- Among nonhospitalized patients, the corresponding rates were 76.1% versus 64.6%, with broader symptom differences.
- Females more frequently reported headache, dizziness, numbness or tingling, pain, fatigue, dyspnea, chest pain, and dysautonomia.
- Nonhospitalized females also reported more brain fog, myalgias, smell or taste disturbance, and gastrointestinal symptoms.
- PROMIS results showed worse subjective fatigue in females; nonhospitalized females performed worse on an objective attention task.
- Interpretation is limited by specialty-clinic referral bias, self-reported symptoms, absent contemporaneous controls, and multiple comparisons without study-wide adjustment.
Practice Applications
- Recognize that persistent Neuro-PASC may present with a broader symptom constellation in female patients.
- Evaluate cognition, fatigue, autonomic symptoms, pain, headache, and sensory complaints without relying on examination findings alone.
- Interpret sex differences as observational associations rather than evidence of distinct causal mechanisms.
- Avoid dismissing persistent multisystem complaints when routine neurologic findings are limited or inconsistent.
PATIENT EDUCATION
OBESITY/WEIGHT MANAGEMENT
EXERCISE/TRAINING
LEGAL MATTERS
GUIDELINES/RECOMMENDATIONS